TotalMarketCap

Fennec Pharmaceuticals

FENCNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$327.568 M

$9.35 -9.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Fennec Pharmaceuticals (FENC) has a market capitalization of $327.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$44.6M

#2751 by revenue

Earnings

-$9.74B

Loss-making

Shares outstanding

35,067,159

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #76Autolus TherapeuticsAUTL$332.7M
  2. #77AgomAb TherapeuticsAGMB$332.4M
  3. #78Fennec PharmaceuticalsFENC$327.6M
  4. #79ProkidneyPROK$322.0M
  5. #80Eikon TherapeuticsEIKN$315.8M

What if Fennec Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$805,984.87

Per share 86,202× higher

Bitcoin $1.53T

$43,610.44

Per share 4,664× higher

Apple $5.02T

$143,169.00

Per share 15,312× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Fennec Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.